Severe neurotoxicities in a case of charcot-marie-tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia

Journal of Pediatric Hematology/Oncology

Volumn 30, Issue 7, 2008, Pages 519-521

  Nishikawa, Takuro ^a,c   Kawakami, Kiyoshi ^a   Kumamoto, Takashi ^a   Tonooka, Shiro ^a   Abe, Akiko ^b   Hayasaka, Kiyoshi ^b   Okamoto, Yasuhiro ^c   Kawano, Yoshifumi ^c  

^a Kagoshima City Hospital   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Acute lymphoblastic leukemia; Charcot marie tooth disease type 2; Neuropathy; Vincristine

Indexed keywords

ASPARAGINASE; CD19 ANTIGEN; CD20 ANTIGEN; CD79A ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ANEMIA; ARTICLE; ATROPHY; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CERVICAL LYMPHADENOPATHY; CHILDHOOD LEUKEMIA; CONVALESCENCE; DISEASE EXACERBATION; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAPHY; ELECTROPHYSIOLOGY; GAIT DISORDER; GRIP STRENGTH; HEPATOMEGALY; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; LEUKEMIA REMISSION; LEUKOCYTOSIS; LIMB DISEASE; LYMPHOBLAST; MALE; MOTOR NERVE CONDUCTION; MUCOSAL BLEEDING; MULTIPLE CYCLE TREATMENT; MUSCLE MALFORMATION; MUSCLE STRENGTH; MUSCLE WEAKNESS; NEUROTOXICITY; PERONEUS NERVE PARALYSIS; PRIORITY JOURNAL; PURPURA; SENSORY DYSFUNCTION; SIDE EFFECT; SPLENOMEGALY; TENDON REFLEX; ULNAR NERVE; WALKING; B CELL LEUKEMIA; CHEMICALLY INDUCED DISORDER; DRUG CONTRAINDICATION; DRUG EFFECT; LYMPHATIC LEUKEMIA; NERVE CONDUCTION; NEUROLOGIC DISEASE; PERIPHERAL NEUROPATHY; REMISSION;

6-MERCAPTOPURINE; ADOLESCENT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; CHARCOT-MARIE-TOOTH DISEASE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; GAIT DISORDERS, NEUROLOGIC; HUMANS; MALE; METHOTREXATE; MUSCLE WEAKNESS; NEURAL CONDUCTION; PERIPHERAL NERVOUS SYSTEM DISEASES; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDNISOLONE; REMISSION INDUCTION; VINCRISTINE;

EID: 54449099121     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31816624a4     Document Type: Article

References (12)

1. Smith SA, Ouvrier R. Hereditary neuropathies. In: Swaiman KF, Ashwal S, Ferriero DM, eds. Pediatric Neurology. 4th ed. Philadelphia: Mosby Inc; 2006:1894-1901.
2. Sarnat HB. Hereditary motor-sensory neuropathies. In: Behrman RE, Kliegman RM, Jenson HB, eds. Textbook of Pediatrics. 17th ed. Philadelphia: WB Saunders; 2004:2076-2078.
3. Zuchner S, Vance JM. Mechanisms of disease: a molecular genetic update on hereditary axonal neuropathies. Nat Clin Pract Neurol.2006;2:45-53.
4. Szigeti K, Garcia CA, Lupski JR. Charcot-Marie-Tooth disease and related hereditary polyneuropathies: molecular diagnostics determine aspects of medical management. Genet Med. 2006;8:86-92.
5. Graf WD, Chance PF, Lensch MW, et al. Severe vincristine neuropathy in Charcot-Marie-Tooth disease type1A. Cancer.1996;77:1356-1362.
6. Igarashi M, Thompson EI, Rivera GK. Vincristine neuropathy in type 1 and type 2 Charcot-Marie-Tooth disease (hereditary motor sensory neuropathy). Med Pediatr Oncol. 1995;25:113-116.
7. Chauvenet AR, Shashi V, Selsky C, et al. Vincristine-induced neuropathy as the initial presentation of Charcot-Marie-Tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Pediatr Hematol Oncol. 2003;25:316-320.
8. Harding AE, Thomas PK. Genetic aspects of hereditary motor and sensory neuropathy (types1 and 2). J Med Genet. 1980;17:329-336.
9. Frost BM, Lonnerholm G, Koopmans P. Vincristine in childhood leukaemia: no pharmacokinetic rationale for dose reduction in adolescents. Acta Pediatr. 2003;92:551-557.
10. Bermudez M, Fuster JL, Linares E. Itraconazole-related increased vincristine neurotoxicity: case report and review of literature. J Pediatr Hematl Oncol. 2005;27:389-392.
11. Weiden PL, Wright SE. Vincristine neurotoxicity. N Engl J Med.1972;286:1369-1370.
12. Weimer LH, Podwall D. Medication-induced exacerbation of neuropathy in Charcot Marie Tooth disease. J Neurol Sci. 2006; 15:47-54.